Jewett MA - Search Results

1

Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer.

Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Loblaw A, Pond GR, Emami M, Sugar L, Sweet J, Narod SA. Nam RK, et al. Among authors: jewett ma. Can J Urol. 2006 Apr;13 Suppl 2:2-10. Can J Urol. 2006. PMID: 16672122

2

Increasing incidence, but stable mortality, of bladder cancer in Ontario. Analysis of a population sample.

Jewett MA, Pereira G, Nijmeh P, Herschorn S, Honey RJ, Struthers NW, Bruce AW, Barkin M. Jewett MA, et al. Urology. 1991;37(5 Suppl):4-7. doi: 10.1016/0090-4295(91)80126-r. Urology. 1991. PMID: 2021033 No abstract available.

3

A study of post-orchiectomy surveillance in stage I testicular seminoma.

Thomas GM, Sturgeon JF, Alison R, Jewett M, Goldberg S, Sugar L, Rideout D, Gospodarowicz MK, Duncan W. Thomas GM, et al. J Urol. 1989 Aug;142(2 Pt 1):313-6. doi: 10.1016/s0022-5347(17)38742-6. J Urol. 1989. PMID: 2746749

4

Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group.

Goldenberg SL, Klotz LH, Srigley J, Jewett MA, Mador D, Fradet Y, Barkin J, Chin J, Paquin JM, Bullock MJ, Laplante S. Goldenberg SL, et al. Among authors: jewett ma. J Urol. 1996 Sep;156(3):873-7. J Urol. 1996. PMID: 8709351 Clinical Trial.

5

Supportive care is not the only option in prostate cancer patients resistant to hormone therapy: the argument against.

Jewett MA, Khakpour G, Moore MJ. Jewett MA, et al. Eur Urol. 1996;29 Suppl 2:45-8. doi: 10.1159/000473839. Eur Urol. 1996. PMID: 8717463 Review.

6

Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.

Warde P, Gospodarowicz MK, Banerjee D, Panzarella T, Sugar L, Catton CN, Sturgeon JF, Moore M, Jewett MA. Warde P, et al. Among authors: jewett ma. J Urol. 1997 May;157(5):1705-9; discussion 1709-10. J Urol. 1997. PMID: 9112510

7

Prostate specific antigen velocity as a measure of the natural history of prostate cancer: defining a 'rapid riser' subset.

Nam RK, Klotz LH, Jewett MA, Danjoux C, Trachtenberg J. Nam RK, et al. Among authors: jewett ma. Br J Urol. 1998 Jan;81(1):100-4. doi: 10.1046/j.1464-410x.1998.00523.x. Br J Urol. 1998. PMID: 9467484

8

Prostate cancer: 2. Natural history.

Nam RK, Jewett MA, Krahn MD. Nam RK, et al. Among authors: jewett ma. CMAJ. 1998 Sep 22;159(6):685-91. CMAJ. 1998. PMID: 9780970 Free PMC article. Review. No abstract available.

9

CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologic Oncology Group.

Klotz LH, Goldenberg SL, Jewett M, Barkin J, Chetner M, Fradet Y, Chin J, Laplante S. Klotz LH, et al. Urology. 1999 Apr;53(4):757-63. doi: 10.1016/s0090-4295(98)00616-5. Urology. 1999. PMID: 10197852 Clinical Trial.

10

Comparison of molecular and conventional strategies for followup of superficial bladder cancer using decision analysis.

Nam RK, Redelmeier DA, Spiess PE, Sampson HA, Fradet Y, Jewett MA. Nam RK, et al. Among authors: jewett ma. J Urol. 2000 Mar;163(3):752-7. J Urol. 2000. PMID: 10687970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

456 results

Search Page

Filters